Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
The Safety and Feasibility of Transcranial Direct Current Stimulation Combined with Conservative Treatment for Cervicogenic Headaches
EF 2022-23
Résumé
More than 300,000 individuals suffer a whiplash or concussion injury in Canada each year and of those as many as 53% experience cervicogenic headaches (CGH). CGH are characterized by chronic headaches, facial pain and neck mobility issues. These symptoms cause significant functional impairment with 35% of CGH patients failing to return to work within 3 months of injury. Pharmacotherapy and nerve blocks can be used to treat CGH symptoms, but require trial and error, failing to address the underlying causes. Physiotherapy is commonly used to address the structural abnormalities inherent to CGH, but trials have shown limited improvement in pain with physiotherapy alone. This study will explore neuromodulation as a novel treatment option for CGH. Neuromodulation is a broad term to describe electrical activation of specific areas of the brain to change neuronal activity which may improve symptoms and function. Neuromodulation techniques such as transcranial direct current stimulation (tDCS) have demonstrated efficacy in decreasing pain and headache burden in conditions such as arthritis and migraines but have never been explored for treatment of CGH. The proposed study will be a novel double-blinded, sham-controlled, randomized clinical trial evaluating tDCS combined with physiotherapy (6-week targeted exercise program) as a treatment option for patients with CGH. The safety and feasibility of this treatment will be assessed to inform future use in CGH patients. Both immediate and long-term responses (6- and 12-weeks post treatment) to neuromodulation and physiotherapy will be assessed to determine the efficacy of this intervention. This trial will help CGH patients to return to normal daily activities while increasing quality of life through reductions in pain and headache.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486431
Name
Jobin Kaiden
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Safety and Feasibility of Transcranial Direct Current Stimulation Combined with Conservative Treatment for Cervicogenic Headaches
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cervicogenic Headache; Concussion; Exercise; Neuromodulation; Pilot Trial; Post-Traumatic Headache; Primary Motor Cortex; Rehabilitation Therapy; Transcranial Direct Current Stimulation; Whiplash
Abstract
More than 300,000 individuals suffer a whiplash or concussion injury in Canada each year and of those as many as 53% experience cervicogenic headaches (CGH). CGH are characterized by chronic headaches, facial pain and neck mobility issues. These symptoms cause significant functional impairment with 35% of CGH patients failing to return to work within 3 months of injury. Pharmacotherapy and nerve blocks can be used to treat CGH symptoms, but require trial and error, failing to address the underlying causes. Physiotherapy is commonly used to address the structural abnormalities inherent to CGH, but trials have shown limited improvement in pain with physiotherapy alone. This study will explore neuromodulation as a novel treatment option for CGH. Neuromodulation is a broad term to describe electrical activation of specific areas of the brain to change neuronal activity which may improve symptoms and function. Neuromodulation techniques such as transcranial direct current stimulation (tDCS) have demonstrated efficacy in decreasing pain and headache burden in conditions such as arthritis and migraines but have never been explored for treatment of CGH. The proposed study will be a novel double-blinded, sham-controlled, randomized clinical trial evaluating tDCS combined with physiotherapy (6-week targeted exercise program) as a treatment option for patients with CGH. The safety and feasibility of this treatment will be assessed to inform future use in CGH patients. Both immediate and long-term responses (6- and 12-weeks post treatment) to neuromodulation and physiotherapy will be assessed to determine the efficacy of this intervention. This trial will help CGH patients to return to normal daily activities while increasing quality of life through reductions in pain and headache.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jobin, Kaiden
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~